Decheng Capital Global Life Sciences Fund V-B, L.P. — Form D/A
Decheng Capital Global Life Sciences Fund V-B, L.P. of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2025-10-03. The offering totals $700.0M, of which $452.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2025-10-03
- Form: D/A
- Accession: 0001231919-25-000281
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $700.0M
- Amount sold: $452.0M
- Remaining: $248.0M
- Investors: 42
- Date of first sale: 2024-06-18
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-516125
Issuer
- Name: Decheng Capital Global Life Sciences Fund V-B, L.P.
- CIK: 0002026146
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2024
- Address: C/O MAPLES CORPORATE SERVICES LIMITED, GRAND CAYMAN, E9, KY1-1104
- Phone: 345-949-8066
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Xiangmin Cui | Director | Houston, TX |
| Yuheng Qiu | Director | Grand Cayman, E9 |
| N/A NA Decheng Capital Management V (Cayman), LLC | Promoter | Grand Cayman, E9 |
Other filings by this issuer (1)
More